Fentanyl-100 and Thalomid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fentanyl-100 (fentanyl) and Thalomid (thalidomide). Common drug interactions include confusional state among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Fentanyl-100 and Thalomid. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Fentanyl-100?

Fentanyl-100 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 7,047 Fentanyl-100 users. Check the latest studies of Fentanyl-100.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.



On Jul, 11, 2026

15 people who take Fentanyl-100 and Thalomid together, and have interactions are studied.

Fentanyl-100 and Thalomid drug interactions.

What are the common drug interactions of Fentanyl-100 and Thalomid, by gender? *:

female:

  1. Confusional state
  2. Decreased interest
  3. Dehydration (dryness resulting from the removal of water)
  4. Depressed mood
  5. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  6. Fatigue (feeling of tiredness)
  7. Haematemesis (vomiting of blood)
  8. Hot flush (sudden feelings of heat)
  9. Ileus (a painful obstruction of the ileum or other part of the intestine)
  10. Injury

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Arthropathy
  4. Asthenia (weakness)
  5. Balance disorder
  6. Blindness
  7. Bradycardia (abnormally slow heart action)
  8. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  9. Compression fracture (fracture due to pressure caused by injury)
  10. Constipation

What are the common drug interactions of Fentanyl-100 and Thalomid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Anaemia (lack of blood)
  2. Platelet count decreased

50-59:

  1. Haemorrhage (bleeding)
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Cachexia (loss of weight)
  5. Dyspepsia (indigestion)
  6. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  7. Hypotension (abnormally low blood pressure)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

60+:

  1. Spinal column stenosis (narrowing of spinal column)
  2. Urinary tract infection
  3. Nausea (feeling of having an urge to vomit)
  4. Osteomyelitis (infection of bone)
  5. Pneumonia
  6. Vomiting
  7. Activities of daily living impaired
  8. Acute myocardial infarction (acute heart attack)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 3 people, 20.00%
  2. Urinary Tract Infection: 2 people, 13.33%
  3. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 6.67%
  4. Indigestion: 1 person, 6.67%
  5. High Blood Pressure: 1 person, 6.67%
  6. Discomfort: 1 person, 6.67%
  7. Constipation: 1 person, 6.67%
  8. Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 6.67%
  9. Anaemia (lack of blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Fentanyl-100 and Thalomid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fentanyl-100 and Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fentanyl-100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fentanyl-100 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalomid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl and thalidomide (the active ingredients of Fentanyl-100 and Thalomid, respectively), and Fentanyl-100 and Thalomid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: